Home » Topics » Conferences

Conferences
RSS

Lead GnRH antagonist presented at Endocrine Society meeting by Abbott, TAP

June 21, 1999

New therapeutic strategy presented at ADA: dipeptidyl peptidase IV inhibitors

June 21, 1999

New antidiabetic agent presented by Bayer scientists this week in San Diego

June 21, 1999

Antifilarial efficacy of PF-1022A demonstrated in gerbil model

June 21, 1999

Japanese investigators explore natural sources for novel antimalarial agents

June 21, 1999

Trimegestone is potentially superior to MPA for HRT

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Parathyroid hormone plus estrogen restores bone density to normal levels in osteoporotic women

June 21, 1999

Role of imidazoline receptors in hypertension

June 21, 1999

FPTO, a novel cardiovascular agent acting via NO pathways

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...